Clinical Trials Directory

Trials / Completed

CompletedNCT01624116

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

A Comparison of Four Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetic Patients and the Effect of Add-On Acarbose on Glycaemic Excursions During Ramadan Fasting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
161 (actual)
Sponsor
Services Hospital, Lahore · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Type 2 diabetic patients who fast during Ramadan experience swings in glycaemic control between hypoglycaemic troughs and hyperglycaemic spikes. Hence, the dual challenge in fasting diabetics is to identify which treatment modality leads to the most stable blood glucose levels during a fast and how to smooth out these excursions and reduce risks of fast to a minimum.

Detailed description

Study Objectives: * To compare changes in clinical and metabolic parameters from baseline to the end of four weeks fasting in Ramadan between four treatment arms: * diet and lifestyle measures alone. * metformin monotherapy. * combination therapy with metformin + sulfonylurea. * combination therapy with metformin + sitagliptin. * To compare the 24 hour CGMS profile during Ramadan fasting in type 2 diabetic patients before and after addition of acarbose to these pre-existing sub-maximal hypoglycaemic regimens.

Conditions

Interventions

TypeNameDescription
DRUGAcarboseTab.Acarbose 50mg BD for one day in addition to existing medication to 10% of patients in each treatment arm.
OTHERDiet and lifestylePatients would follow a 1200 KCal Ramadan diet plan, and exercise for 30 minutes per day
DRUGMetforminPatients on metformin monotherapy prior to Ramadan will continue on it, in the same dose
DRUGMetformin/ GlimeprideMetformin 500mg and Glimepride 1mg in a combination tablet. Dosage frequency BD
DRUGMetformin/SitagliptinMetformin 500 and sitagliptin 50mg in a combination tablet,dosage frequency BD.

Timeline

Start date
2011-08-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2012-06-20
Last updated
2012-06-20

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT01624116. Inclusion in this directory is not an endorsement.